Taiwan · Delayed Price · Currency is TWD Acer Medical Statistics
Total Valuation
Acer Medical has a market cap or net worth of TWD 1.45 billion. The enterprise value is 1.28 billion.
| Market Cap | 1.45B |
| Enterprise Value | 1.28B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Acer Medical has 15.23 million shares outstanding.
| Current Share Class | 15.23M |
| Shares Outstanding | 15.23M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.78% |
| Owned by Institutions (%) | 0.54% |
| Float | 3.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.21 |
| PB Ratio | 8.82 |
| P/TBV Ratio | 8.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 21.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.74, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.74 |
| Quick Ratio | 4.52 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | -2,518.00 |
Financial Efficiency
Return on equity (ROE) is -16.51% and return on invested capital (ROIC) is -11.30%.
| Return on Equity (ROE) | -16.51% |
| Return on Assets (ROA) | -9.43% |
| Return on Invested Capital (ROIC) | -11.30% |
| Return on Capital Employed (ROCE) | -19.85% |
| Weighted Average Cost of Capital (WACC) | 8.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.28 |
| Inventory Turnover | 4.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.75% in the last 52 weeks. The beta is 0.69, so Acer Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -20.75% |
| 50-Day Moving Average | 97.12 |
| 200-Day Moving Average | 108.70 |
| Relative Strength Index (RSI) | 47.27 |
| Average Volume (20 Days) | 1,328 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Acer Medical had revenue of TWD 60.05 million and -29.69 million in losses. Loss per share was -1.95.
| Revenue | 60.05M |
| Gross Profit | 37.50M |
| Operating Income | -32.73M |
| Pretax Income | -29.69M |
| Net Income | -29.69M |
| EBITDA | -32.16M |
| EBIT | -32.73M |
| Loss Per Share | -1.95 |
Balance Sheet
The company has 178.65 million in cash and 2.50 million in debt, with a net cash position of 176.15 million or 11.57 per share.
| Cash & Cash Equivalents | 178.65M |
| Total Debt | 2.50M |
| Net Cash | 176.15M |
| Net Cash Per Share | 11.57 |
| Equity (Book Value) | 164.92M |
| Book Value Per Share | 10.83 |
| Working Capital | 158.11M |
Cash Flow
In the last 12 months, operating cash flow was -24.65 million and capital expenditures -1.08 million, giving a free cash flow of -25.73 million.
| Operating Cash Flow | -24.65M |
| Capital Expenditures | -1.08M |
| Depreciation & Amortization | 575,000 |
| Net Borrowing | 2.50M |
| Free Cash Flow | -25.73M |
| FCF Per Share | -1.69 |
Margins
Gross margin is 62.45%, with operating and profit margins of -54.51% and -49.43%.
| Gross Margin | 62.45% |
| Operating Margin | -54.51% |
| Pretax Margin | -49.43% |
| Profit Margin | -49.43% |
| EBITDA Margin | -53.55% |
| EBIT Margin | -54.51% |
| FCF Margin | n/a |
Dividends & Yields
Acer Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2.04% |
| FCF Yield | -1.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Acer Medical has an Altman Z-Score of 26.54 and a Piotroski F-Score of 3.
| Altman Z-Score | 26.54 |
| Piotroski F-Score | 3 |